Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
AstraZeneca
Mallinckrodt
Dow
Johnson and Johnson

Last Updated: August 19, 2022

Investigational Drugs with Clinical Trials for: Lymphoma, T-Cell, Peripheral


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Drugname Indication
Chidamide Lymphoma, T-Cell, Peripheral
MEDI4736 Lymphoma, T-Cell, Peripheral
MLN0128 Lymphoma, T-Cell, Peripheral
PRX-03140 Lymphoma, T-Cell, Peripheral
AZD4573 Lymphoma, T-Cell, Peripheral
L-Phenylalanine Lymphoma, T-Cell, Peripheral
BCNU Lymphoma, T-Cell, Peripheral
>Drugname >Indication

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Johnson and Johnson
McKesson
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.